CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 26 filers reported holding CANCER GENETICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $27,000 | -12.9% | 16,489 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $31,000 | -71.3% | 16,489 | -58.9% | 0.00% | -50.0% |
| Q3 2017 | $108,000 | -32.1% | 40,158 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $159,000 | -3.6% | 40,158 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $165,000 | +5.1% | 40,158 | -65.5% | 0.00% | 0.0% |
| Q4 2016 | $157,000 | – | 116,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 581,200 | $1,157,000 | 1.33% |
| Fairbanks Capital Management, Inc. | 233,170 | $464,000 | 0.56% |
| DIKER MANAGEMENT LLC | 29,815 | $59,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 199,580 | $397,000 | 0.02% |
| Sterneck Capital Management, LLC | 14,750 | $29,000 | 0.02% |
| Spot Trading L.L.C | 151,900 | $302,000 | 0.01% |
| Acrospire Investment Management LLC | 3,514 | $7,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 84,320 | $168,000 | 0.01% |
| BECK MACK & OLIVER LLC | 18,225 | $36,000 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 47,600 | $94,000 | 0.00% |